Skip to content
Apply
Stories

Study finds life-saving COVID-19 treatments didn’t make it to US patients recently infected

People in this story

Photo by: Fabian Sommer/picture-alliance/dpa/AP Images
01 March 2022, Berlin: A person holds the drug Paxlovid against Covid-19 from the manufacturer Pfizer.

Paxlovid and Molnupiravir, two leading COVID-19 antiviral medications, are life-saving drugs that have been shown to reduce deaths, in Paxlovid’s case, by a factor of 10 in the most severe cases.

However, according to new research published Wednesday by the COVID States Project, the two treatments have been vastly underutilized in the U.S., renewing concerns about the extent to which the federal government’s oft-criticized COVID-19 response contributed to preventable deaths from the disease.

The research is based on a nationwide survey that was conducted between June 8 and July 6 involving 24,414 respondents. Of them, 43% said they had been infected with COVID-19 recently; and of those who were sick between May and early July, only 11% reported having taken the antivirals, the data shows. The antiviral drugs are typically used at the onset of symptoms to blunt the progression of disease, according to the Centers for Disease Control and Prevention.  

Continue reading at News@Northeastern.

More Stories

Maria Ivanova, Northeastern's new director of the School of Public Policy and Urban Affairs, poses for a portrait on Tuesday, Aug. 23, 2022.

Maria Ivanova receives Global Green Mentor award at Climate Week NYC — but she’s just getting started

James Alan Fox newspaper clipping. Headline reads:

How Northeastern’s James Alan Fox pioneered the study of mass murder

10.26.2023
Ingredients for local Khmer dishes in Siem Reap, Cambodia.

Dialogue of Civilizations Spotlight: Food and Culture in Vietnam and Cambodia

11.16.23
Student Stories